Latest Breaking News On - Clin gastroenterol hepatol - Page 1 : vimarsana.com

Ipsen s Iqirvo® receives U S FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis | Company Announcement

Ipsen s Iqirvo® receives U S FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis | Company Announcement
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

United statesFrance generalUnited kingdomHong kongIpsen euronextClin gastroenterol hepatolCarol robertsChristelle huguetAnna gibbinsIpsen iqirvoRachel reiffKris kowdleyNicolas boglerAmy wolfLiver instituteIpsen pharmaceuticals inc

Ipsen Pharma: Ipsen s Iqirvo® receives U S FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

Iqirvo® (elafibranor) 80 mg tablets is the first new medicine approved in nearly a decade for the treatment of the rare liver

France generalUnited statesUnited kingdomHong kongChristelle huguetRachel reiffKris kowdleyNicolas boglerAnna gibbinsAmy wolfCarol robertsClin gastroenterol hepatolIpsen euronextIpsen pharmaceuticals incRegulatory agencyLiver institute

Ipsen s Iqirvo® receives U S FDA accelerated approval as a

Ipsen s Iqirvo® receives U S FDA accelerated approval as a
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

France generalUnited statesHong kongUnited kingdomCarol robertsAnna gibbinsRachel reiffIpsen euronextClin gastroenterol hepatolNicolas boglerAmy wolfChristelle huguetKris kowdleyEuropean medicines agencyIpsen pharmaceuticals incFibrotic liver disease consortium investigators

PSC Partners Announces the First Patient Enrolled Into the WIND-PSC Study, a Global Prospective Cohort to Support the Development of New Treatments for Primary Sclerosing Cholangitis

PSC Partners and PSC Partners Canada, both patient-led non-profit organizations supporting education and research in primary sclerosing cholangitis (PSC), announced today the enrollment of the first patient into the WIND-PSC study. PSC is a rare.

Nordrhein westfalenUnited statesChristopher bowlusClin gastroenterol hepatolBettina hansenGideon hirschfieldGulamhuseina seminChristoph schrammStephen rossiArbor research collaborative for healthUniversity of miamiUniversity of californiaProduct serviceErasmus universityMd university of torontoData coordinating center

Blood-Based Test Offers Effective Screening Option for Colorectal Cancer

Data from PREEMPT CRC reveal the blood-based screening test demonstrated a 79.2% sensitivity for detecting colorectal cancer.

United statesAasma shaukatClin gastroenterol hepatolMaryh glickmanAmerican cancer societyYork university grossman school of medicineYork university aasma shaukatNew york universityDigestive disease weekNew york university grossman schoolAfrican americanBlood based screening testEarly detectionGastroenterologists present clinical findingsMed clin northTest increases colorectal cancer screening